SMTL ID : 4wz6.1

Human CFTR aa389-678 (NBD1), deltaF508 with three solubilizing mutations, bound ATP

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.05 Å

Oligo State

monomer

Ligands

1 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)

ATP.1: 13 residues within 4Å: Chain A: W.14, V.53, S.72, T.73, G.74, A.75, G.76, K.77, T.78, S.79, M.82, Q.106 Ligands: MG.2 16 PLIP interactions: 16 interactions with chain A Hydrogen bonds: A:G.74, A:A.75, A:G.76, A:G.76, A:K.77, A:T.78, A:T.78, A:S.79, A:S.79, A:Q.106 Water bridges: A:T.73, A:S.185, A:N.271 Salt bridges: A:K.77, A:K.77 pi-Stacking: A:W.14

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 4 residues within 4Å: Chain A: K.77, Q.106, S.185 Ligands: ATP.1 3 PLIP interactions: 1 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:S.185, H2O.2, H2O.2

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hall, J.D. et al., Binding screen for cystic fibrosis transmembrane conductance regulator correctors finds new chemical matter and yields insights into cystic fibrosis therapeutic strategy. Protein Sci. (2016)

Release Date

2015-11-11

Peptides

Cystic fibrosis transmembrane conductance regulator: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cystic fibrosis transmembrane conductance regulator

Related Entries With Identical Sequence